World Health Organisation chief to attend opening of Edinburgh research hub
The director-general of the World Health Organisation (WHO) will be among the guests attending the opening of a state-of-the-art research hub hailed as a 'major step forward' in improving health and social care.
The new Usher Building, in the Edinburgh BioQuarter, houses more than 900 researchers, health and care providers and industry leaders, all harnessing the power of data to address some of the country's most pressing health challenges.
These include an ageing population, widening health inequalities and childhood wellbeing – all against a backdrop of increasing pressure on services.
WHO director-general Dr Tedros Adhanom Ghebreyesus will be joined at the opening by Scotland Secretary Ian Murray and Secretary for Drug and Alcohol Policy Maree Todd, alongside University of Edinburgh staff and students.
During the event Dr Tedros will be given the university's inaugural Edinburgh Prize for Global Health Impact, in recognition of the WHO's work to make life-saving vaccinations accessible to children across the world.
Speaking ahead of the event Dr Tedros said: 'For hundreds of years, the University of Edinburgh has been a revered centre of learning and research.
'With the Usher Building's opening, the university is future-proofing that proud heritage by embracing the latest medical innovations, artificial intelligence and data analysis to contribute to making a healthier world.' PA Media The WHO director-general said the new facility would 'future-proof' the university's research heritage (Niall Carson/PA).
The building came into use last year, and a number of 'pioneering' projects are already taking place within its walls.
These include the DataLoch initiative, which brings together anonymised data from everyday use of health and social services, which researchers can use to investigate issues ranging from service improvement to health inequalities.
DataLoch also supports researchers in accessing health and care data linked to other datasets, to build a clearer picture of the links between health and social factors.
One such study, Health Homes, Healthy Kids, is combining data from prepayment smart meters and health records to explore, for the first time, the links between underheated homes and children's health.
Meanwhile, genetic studies of populations in Shetland, Orkney and the Hebrides are yielding valuable insights into cancer genetics, while health data experts track population trends to enhance prevention, diagnosis and care delivery.
Professor Sir Peter Mathieson, principal and vice-chancellor of the University of Edinburgh, said: 'The opening of the Usher Building is a major step forward for the University of Edinburgh – and wider society – in reimagining how we improve health and social care.
'By bringing together researchers, clinicians and industry experts, we have created a dynamic hub that will drive innovation for the benefit of all.
'It is inspiring to shine a light on the outstanding work under way here and, together with the United Nations and many other key partners, we remain committed to advancing these critical efforts to improve lives.' PA Media Secretary for Drug and Alcohol Policy Maree Todd said the new facility marks a 'significant step forward in health innovation' (Andrew Milligan/PA).
The university received £49.2m capital funding for the building through the Edinburgh & South East Scotland City Region Deal, with £48.5m from the UK Government and £0.7m from the Scottish Government.
It is one of six 'innovation hubs' to receive funding under the deal, and joins a growing health innovation ecosystem in Edinburgh.
Mr Murray said: 'I am very much looking forward to attending the opening of this fantastic state-of-the-art facility alongside so many eminent guests from the health and social care sectors.
'Backed by £48.5 million of UK Government funding, the Usher Institute provides an inspiring environment where academics, healthcare professionals and industry partners can collaborate on pioneering research and development to tackle challenges faced by our communities and improve wellbeing.
'This is our Plan for Change in action, working with partners to deliver economic growth and a decade of national renewal.'
Maree Todd said the opening marks a 'significant step forward in health innovation'.
She said: 'The innovations by the Usher Institute will help renew the NHS in Scotland, and, as a WHO Collaborating Centre, transform healthcare around the globe.
'This development will drive growth across the region, which is why the Scottish Government is proud to support it through our Edinburgh and South East Scotland City Region Deal investment.'
Get all the latest news from around the country Follow STV News
Scan the QR code on your mobile device for all the latest news from around the country
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Edinburgh Reporter
14 hours ago
- Edinburgh Reporter
Inaugural Edinburgh Prize presented to the World Health Organisation
At the official opening of the Usher Building in Edinburgh Bioquarter on Thursday the Director General of the World Health Organisation (WHO), Dr Tedros Adhanom Ghebreyesus accepted the first Edinburgh Prize for Global Health Impact on behalf of the organisation. The prize recognises the organisation's programme during the last half century to provide life-saving vaccines for children all over the world. The Director General was emphatic in his view of the programme's impact. He said: 'Since 1974, 154 million lives were saved. So vaccine works, vaccine helps children survive. And that is actually what this prize from the University of Edinburgh is saying and the WHO has contributed significantly to this.' Dr Tedros officially opened the £50 million plus building constructed with funding from The Edinburgh and South East Scotland City Region Deal – the £1.5 billion deal funded by both the UK and the Scottish Governments and which involves six local authorities in the area. Funding also came from The Wolfson Foundation. Dr Tedros Ghebreyesus of @ officially opens the £50 million + Usher Building in Edinburgh today — The Edinburgh Reporter (@ 2025-06-26T11:59:30.076Z This building is part of the Data-Driven Innovation part of the City Region Deal and is one of six hubs supported by the initiative. The building is a co-location hub where more than 900 researchers and scientists will work alongside health and social care providers and industry leaders to use data to provide healthcare solutions. Professor Sir Peter Mathieson, Principal and Vice-Chancellor of the University of Edinburgh said that with his background as a medical doctor he does have some understanding of the work to be carried out in the Usher Building. He said: 'I'm no longer an active researcher, but the ethos of the building is very multidisciplinary. It's the product of a collaboration between the two governments in Westminster and Holyrood in terms of funding, and also the Wolfson Foundation, which is also a very important contributor. But the work itself is very collaborative and across disciplines, across areas and subjects, and also across nations. Sir Peter explained that what the research will provide is facts and data. He cited the example of NHS waiting lists which were 'already under strain prior to the pandemic'. He said: 'it's not as if the pandemic caused all the problems, but what the pandemic did is it brought the problems of the pandemic, but it also put everything else into second place, if you like. So there was then a backlog built up, and we now have this extraordinary number of people on NHS waiting lists in Scotland and in the rest of the UK, with the NHS struggling to keep up. So researchers here will are providing facts and that is really useful for governments to understand where the priorities are. Good policy is formed from good data and good data is formed from multidisciplinary collaborations.' The Rt Hon Ian Murray explained that he is an alumnus of the University of Edinburgh and that it was especially good to be at the opening of the new building. He explained that the UK Government involvement in the City Region Deal had contributed significantly towards the building with a contribution of £48.5 million. He said: 'The real reason for that kind of contribution was to provide buildings like this that can innovate, provide us with the research and development of the future, to bring financiers, partners, institutions, organisations, businesses and researchers all together to collaborate under one roof, to give us that healthcare of the future.' WHO funding Asked about the ongoing challenged of funding the WHO, (In May the WHO reduced its management team and scaled back its operations after the United States announced it was leaving the agency and cutting its financial support leading to a 21% cut in the organisation's budget), Dr Tedros said that they had 'seen it coming' in 2017 when they started the transformation of the WHO. He said: 'The major risk we identified was reliance on a few traditional donors – because if any one of them reduces their funding, the same situation could happen, and the organisation cannot absorb it. 'Not only that, when you rely on only a few traditional donors that also can affect your independence. So at that time, we said we have to broaden our donor base, and that can help us get flexible funding, long term funding. At the same time, it will make WHO more independent, because we rely on almost all 194 countries. 'Our funding started to be broadened out, and it's helping us to minimise the pain due to the current crisis. The contribution that was provided during the last two to three years is helping us to save jobs. We are seeing this as an opportunity. It's a crisis but as an opportunity we will emerge better.' In this imposing building looking down on the Royal Infirmary of Edinburgh there is pioneering work taking place with researchers leveraging artificial intelligence to improve surgical outcomes and scientists exploring diagnostic potential through routine retina imaging. WHO Director-General, Dr Tedros Adhanom Ghebreyesus L-R The Rt Hon Ian Murray MP Secretary of State for Scotland, Maree Todd MSP. Minister for Drug and Alcohol Policy and Sport and WHO Director-General, Dr Tedros Adhanom Ghebreyesus who officially opened the Usher Building Some of the 900 academics and researchers who work in the building at the official launch The Rt Hon Ian Murray Secretary of State for Scotland Professor Sir Peter Mathieson, Principal and Vice-Chancellor of the University of Edinburgh WHO Director-General, Dr Tedros Adhanom Ghebreyesus Professor Sir Peter Mathieson, Principal and Vice-Chancellor of the University of Edinburgh speaking to members of the Usher family on the left of the photo Like this: Like Related
Telegraph
18 hours ago
- Telegraph
Hoping that viruses will go away is not enough – what is needed is continuous vigilance
In the public debate about pandemics, there is a belief as persistent as it is dangerous: the idea that epidemics end, that viruses – once contained – will disappear like a summer storm. But virology and epidemiology teach us that viruses do not disappear. Viruses adapt and mutate. They lurk in the folds of health inequalities and gaps in global surveillance. The latest alarm comes from Sierra Leone, which, after reporting its first two cases of mpox (formerly known as monkeypox) in January and declaring a public health emergency, is now facing a significant expansion of the epidemic. According to official sources, the country has reported over 3,000 confirmed cases and at least 15 deaths, with infections concentrated particularly in Western Area Urban, Western Area Rural, and Bombali. National health authorities, assisted by the WHO, Unicef, Africa CDC, and Gavi, have implemented a comprehensive emergency plan: strengthening surveillance, isolating cases, contact tracing, and launching awareness campaigns in schools and rural communities. As a result, 61,300 doses of the MVA-BN vaccine are expected to arrive in the coming weeks, and hundreds of health workers are being trained on diagnostic, treatment, and prevention protocols. This outbreak is becoming particularly worrisome due to the high vulnerability of children, who face a mortality risk up to four times higher than adults, especially in conditions of malnutrition or poor hygiene. On a continental scale, Africa is witnessing a rise in cases, with over 50,000 reported since the beginning of the year and more than 1,700 deaths. A critical factor is the viral clade involved. While full genomic mapping is still underway, the Africa CDC has reported that clade IIb, which has been associated with faster human-to-human transmission and potentially exponential spread, is likely the dominant strain in Sierra Leone. Despite Sierra Leone's improved emergency response capacity, gained during the 2014-2016 Ebola outbreak, healthcare infrastructure remains under strain. Patients often share beds, and clinical recognition delays persist, reflecting systemic pressures that could hamper containment efforts. Viruses return when the world 'moves on' Recent history, from Covid-19 to polio, shows that viruses do not 'die out' with a decree or a short-lived vaccination campaign. Zoonotic viruses, in particular, have an inherent ability to remain in circulation between animal and human hosts, often with different symptomatologies, and to re-emerge under favourable conditions. When surveillance loosens, when public health is underfunded, when the world 'moves on,' viruses return. Mpox is emblematic in this regard. For decades considered a virus confined to parts of central Africa, it has found new vectors, new susceptible populations, and new routes of transmission. Its recent mutations – linked to clade IIb – suggest adaptations to human infection that could make it endemic even in hitherto unaffected areas. Its apparent disappearance in high-income countries after the 2022-2023 wave is illusory: it was not a biological defeat, but a logistical suspension. Yet there are examples of good health behaviour from which the whole world should draw inspiration. In Tanzania in 2023, a small outbreak of Marburg virus – one of the world's deadliest pathogens, belonging to the same family as Ebola – was contained through a timely, transparent and coordinated response. The Tanzanian Ministry of Health quickly put in place measures for contact tracing, case isolation, effective public communication and cooperation with WHO. Similar efficiency was demonstrated in Rwanda, where preparedness for potential Marburg cases became a pillar of public health strategy, despite the fact that no outbreaks had occurred. Both countries invested in decentralised surveillance systems, widespread health training, and integration of human and veterinary medicine-embodying the concept of 'One Health'. These examples show that prevention is not a luxury of rich countries, but a strategic choice that is possible everywhere if supported by political will and real, non-paternalistic international cooperation. The new mpox outbreak in Sierra Leone must be interpreted in light of a fundamental fact: the transmissibility of viruses knows no geopolitical boundaries. Emerging diseases are now more than ever a global health security issue. A delay in diagnosis in Freetown can trigger an infection in Paris, London or Toronto within days. Yet funding for surveillance and diagnostic laboratories remains concentrated in a few areas. Large regions of Africa, Asia, and Latin America lack sentinel systems capable of detecting new threats in real time. Where the first patient is not identified, the virus has already won the first round. Continuing to hope that 'it won't happen here,' or that 'this time it is just a small outbreak,' is a mistake we have already paid dearly for. The mpox emergency in Sierra Leone is not yet a pandemic, but it is already an opportunity: to invest, to coordinate, to train. Epidemiological surveillance must become a structural and continuous investment, not an emergency response. We need a global network that not only responds, but predicts. One that recognises the global potential in seemingly minor outbreaks, and that funds local health systems not just to treat, but to monitor and to anticipate. Hoping that viruses will disappear is an understandable but naive wish. The only scientifically sound response is permanent, equitable, multilevel surveillance. We can no longer afford to ignore weak signals. Every contained outbreak is a shared victory; every ignored outbreak is a global defeat waiting to happen. Francesco Branda is an Adjunct professor at the Faculty of Medicine and Surgery at Campus Bio-Medico University of Rome Protect yourself and your family by learning more about Global Health Security
The Independent
a day ago
- The Independent
US pulls funding from global vaccines group, saying it has 'ignored the science'
U.S. Health Secretary Robert F. Kennedy Jr. said the country is pulling its support from the vaccines alliance Gavi, saying the organization has 'ignored the science' and 'lost the public trust.' A video of Kennedy's speech was shown to participants at a Gavi meeting in Brussels on Wednesday, where the vaccines group was hoping to raise at least $9 billion for the next five years. Gavi is a public-private partnership including WHO, UNICEF, the Gates Foundation and the World Bank. It has paid for more than 1 billion children to be vaccinated through routine immunization programs, saving an estimated 18 million lives. The U.S. has long been one of its biggest supporters; before Trump's re-election, the country had pledged $1 billion through 2030. Kennedy called on Gavi 'to re-earn the public trust and to justify the $8 billion America has provided in funding since 2001,' saying officials must 'consider the best science available, even when that science contradicts established paradigms.' Kennedy said until that happens, the U.S. won't contribute further to Gavi. Kennedy, a longtime vaccine skeptic, said he and President Trump were concerned about how Gavi and the World Health Organization partnered together during the COVID-19 pandemic to work with social media companies 'to silence dissenting views, to stifle free speech and legitimate questions' during a time when many people had questions about vaccine safety. Kennedy said Gavi continues to make 'questionable recommendations,' like advising pregnant women to get immunized against COVID-19 and funding the roll-out of a vaccine against diphtheria, tetanus and pertussis in poorer countries. WHO and other health authorities have recommended pregnant women get vaccinated against COVID-19, saying they are at higher risk of severe disease. Kennedy said he has seen research that concluded that young girls vaccinated against diphtheria, tetanus and pertussis were more likely to die from all other causes than children who weren't immunized. Gavi said in a statement Thursday that its 'utmost concern is the health and safety of children.' The organization said any decision it makes on vaccines to buy is done in accordance with recommendations issued by WHO's expert vaccine group. 'This ensures Gavi investments are grounded in the best available science and public health priorities,' it said. Gavi said scientists had reviewed all available data, including any studies that raised concerns, and that the diphtheria, tetanus and pertussis vaccine has 'played a key role in helping halve childhood mortality.' The British government said Wednesday it would give 1.25 billion pounds ($1.7 billion) between 2026 and 2030 to Gavi. It said the money would help Gavi protect up to 500 million children in some of the world's poorest countries from diseases including meningitis, cholera and measles. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
